| Title |
Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels
|
|---|---|
| Published in |
Cancer Management and Research, March 2022
|
| DOI | 10.2147/cmar.s348591 |
| Pubmed ID | |
| Authors |
Norikazu Masuda, Yucherng Chen, Tsutomu Kawaguchi, Koji Dozono, Masakazu Toi |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 1 | 7% |
| Researcher | 1 | 7% |
| Lecturer | 1 | 7% |
| Other | 1 | 7% |
| Unknown | 11 | 73% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 13% |
| Computer Science | 1 | 7% |
| Nursing and Health Professions | 1 | 7% |
| Unknown | 11 | 73% |